Article
Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types.
British journal of cancer - 27 May 2014
Kavanagh K, Pollock K G J, Potts A, Love J, Cuschieri K, Cubie H, Robertson C, Donaghy M
Abstract excerpt
BACKGROUND: In 2008, a national human papillomavirus (HPV) immunisation programme began in Scotland for 12-13 year old females with a three-year catch-up campaign for those under the age of 18. Since 2008, three-dose uptake of bivalent vaccine in the routine cohort aged 12-13 has exceeded 90% annually, while in the catch-up cohort overall uptake is 66%. METHODS: To monitor the impact of HPV immunisation, a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
